CALIN: Immediate Skin-to-skin Contact After C-section

Sponsor
Université de Sherbrooke (Other)
Overall Status
Completed
CT.gov ID
NCT01862432
Collaborator
(none)
60
1
2
20.1
3

Study Details

Study Description

Brief Summary

At birth, the passage from intrauterine to the aerial life can be considered as one of the most stressful and painful life events. Skin-to-skin contact (STSC) with mother is known to provide numerous virtues and World Health Organisation (WHO) recently supported the introduction of such care among healthy, term-born neonates. Here, the investigators hypothesized that immediate STSC could reduce neonatal, birth-evoked stress and pain. This randomized controlled trial (RCT) aimed to compare the pain and stress response of C-section born neonates that received either immediate STSC with mother (intervention) or classical support and monitoring (control).

Condition or Disease Intervention/Treatment Phase
  • Other: Immediate skin-to-skin
N/A

Detailed Description

Women are recruited before elective c-section.

Randomizatiion is performed just before the operation.

Control group:

The operation is performed as usual, with observation of the newborn by medical staff. The newborn is then wrapped in a blanket and given to the father.

Intervention group:

The newborn is given to the mother in the first minute of life, placed on her chest to allow complete skin-to-skin contact. Observation of the baby is performed in this position. The skin-to-skin contact lasts as long as the operation is not completed or the mother is not able anymore to keep her baby on her chest.

Sampling (in both groups):
  • salivary samples are obtained with salivettes from the mother 1)before the operation and
  1. after the operation, in the recovery room (90 minutes after birth).
  • salivary samples are obtained with salivettes from the newborn 1) 20 minutes after birth and 2) 20 minutes after the vitamin K injection (performed at 60 minutes of life)

  • A cord blood sample is obtained for prolactin, ACTH and cortisol analysis.

Video recording:

The newborn is video recorded at the vitamin K injection (from 1 minute before the injection to 5 minutes after) for analysis with the Neonatal Infant Pain Scale.

Satisfaction:

The mother's satisfaction is evaluated with a questionnaire 24 to 48 hours after birth.

Breastfeeding:

The breastfeeding is evaluated by a research nurse 1) at the hospital and 2) by phone interviews, up to 6 months after birth.

Study Design

Study Type:
Interventional
Actual Enrollment :
60 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Official Title:
Immediate Skin-to-skin Contact After Caesarean Delivery to Improve Neonatal
Study Start Date :
Jun 1, 2011
Actual Primary Completion Date :
Feb 1, 2013
Actual Study Completion Date :
Feb 1, 2013

Arms and Interventions

Arm Intervention/Treatment
Experimental: immediate skin-to-skin

Other: Immediate skin-to-skin
The newborn is place on his mother's chest, immediately (in the first minute of life), in order to allow complete skin-to-skin contact.

No Intervention: control

Outcome Measures

Primary Outcome Measures

  1. Breastfeeding at six months [six months]

Secondary Outcome Measures

  1. Pain reactivity [one hour]

    The newborn reactivity to pain is analyzed one hour after birth, at the injection of vitamin K, according to the Neonatal Infant Pain Scale.

  2. mother's satisfaction [48 hours]

    Mother's satisfaction is evaluated by a questionnaire, within 48 hours after C-section.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • elective C-section

  • term pregnancy

  • signature of an information and consent form

Exclusion Criteria:
  • multiple pregnancy

  • labor

  • fetal distress

  • abnormal anticipated birth weight

  • congenital malformation

  • diabetes

  • fever

  • rapid management of the new born required

Contacts and Locations

Locations

Site City State Country Postal Code
1 Centre Hospitalier Universitaire de Sherbrooke Sherbrooke Quebec Canada J1H 5N4

Sponsors and Collaborators

  • Université de Sherbrooke

Investigators

  • Principal Investigator: Jean-Charles Pasquier, MD, PhD, Université de Sherbrooke

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Jean-Charles Pasquier, MD, PhD, Dr, Université de Sherbrooke
ClinicalTrials.gov Identifier:
NCT01862432
Other Study ID Numbers:
  • 10-097
First Posted:
May 24, 2013
Last Update Posted:
May 24, 2013
Last Verified:
May 1, 2013

Study Results

No Results Posted as of May 24, 2013